Vinva Investment Management’s Edwards Lifesciences EW Stock Holding History

Vinva Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$718K	Buy	9,027 +5,792	+179%	+$478K	0.01%	366
2025 Q4	$279K	Buy	+3,235	New	+$265K	﹤0.01%	379
2024 Q4	–	Sell	-10,011	Closed	-$667K	–	423
2024 Q3	$667K	Sell	10,011 -15,135	-60%	-$1.1M	0.03%	345
2024 Q2	$2.35M	Buy	25,146 +1,417	+6%	+$125K	0.12%	188
2024 Q1	$2.27M	Buy	23,729 +784	+3%	+$65.9K	0.13%	190
2023 Q4	$1.76M	Buy	22,945 +3,641	+19%	+$253K	0.12%	190
2023 Q3	$1.35M	Buy	19,304 +106	+0.6%	+$8.52K	0.13%	168
2023 Q2	$1.77M	Sell	19,198 -1,651	-8%	-$143K	0.15%	160
2023 Q1	$1.7M	Buy	+20,849	New	+$1.64M	0.14%	167

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vinva Investment Management's EW Position: Q1 2026 in Review

Vinva Investment Management increased its Edwards Lifesciences (EW) stake by 179% in Q1 2026, buying an estimated $478K and bringing the position to 9,027 shares worth $718K. The position accounts for 0.01% of the portfolio, ranked #366.

Vinva Investment Management first reported a position in EW in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.35M in Q2 2024. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Vinva Investment Management held 9,027 shares of Edwards Lifesciences worth $718K as of Q1 2026.
Vinva Investment Management bought 5,792 Edwards Lifesciences shares in Q1 2026, an estimated $478K.
Edwards Lifesciences made up 0.01% of Vinva Investment Management's portfolio in Q1 2026, its #366 holding.
Vinva Investment Management first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 9 quarters since.
Vinva Investment Management's Edwards Lifesciences position peaked at $2.35M in Q2 2024.
1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.